DK1828131T3 - Piperidinsulfonylurinstoffer og -thiourinstoffer, deres fremstilling, deres anvendelse og farmaceutiske sammensætninger indeholdende samme - Google Patents
Piperidinsulfonylurinstoffer og -thiourinstoffer, deres fremstilling, deres anvendelse og farmaceutiske sammensætninger indeholdende sammeInfo
- Publication number
- DK1828131T3 DK1828131T3 DK05811326T DK05811326T DK1828131T3 DK 1828131 T3 DK1828131 T3 DK 1828131T3 DK 05811326 T DK05811326 T DK 05811326T DK 05811326 T DK05811326 T DK 05811326T DK 1828131 T3 DK1828131 T3 DK 1828131T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical compositions
- formula
- thioureas
- sulfonylureas
- piperidine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 229940100389 Sulfonylurea Drugs 0.000 title 1
- 150000003585 thioureas Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000031229 Cardiomyopathies Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 102000016924 KATP Channels Human genes 0.000 abstract 1
- 108010053914 KATP Channels Proteins 0.000 abstract 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004061017A DE102004061017A1 (de) | 2004-12-18 | 2004-12-18 | Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| PCT/EP2005/013087 WO2006063722A1 (en) | 2004-12-18 | 2005-12-07 | Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1828131T3 true DK1828131T3 (da) | 2008-09-29 |
Family
ID=35811666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05811326T DK1828131T3 (da) | 2004-12-18 | 2005-12-07 | Piperidinsulfonylurinstoffer og -thiourinstoffer, deres fremstilling, deres anvendelse og farmaceutiske sammensætninger indeholdende samme |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8586612B2 (pt) |
| EP (1) | EP1828131B1 (pt) |
| JP (1) | JP5231807B2 (pt) |
| KR (1) | KR101261251B1 (pt) |
| CN (1) | CN101080388B (pt) |
| AT (1) | ATE397588T1 (pt) |
| AU (1) | AU2005315927B2 (pt) |
| BR (1) | BRPI0515770A (pt) |
| CA (1) | CA2590405C (pt) |
| DE (2) | DE102004061017A1 (pt) |
| DK (1) | DK1828131T3 (pt) |
| ES (1) | ES2306252T3 (pt) |
| IL (1) | IL183807A (pt) |
| MX (1) | MX2007006679A (pt) |
| PT (1) | PT1828131E (pt) |
| WO (1) | WO2006063722A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY33755A (es) | 2010-11-30 | 2012-06-29 | Astrazeneca Ab | Nuevos bloqueadores de ikach |
| CN104788425A (zh) * | 2015-03-12 | 2015-07-22 | 佛山市赛维斯医药科技有限公司 | 一类含烟酸酰胺和哌啶结构ptp1b抑制剂、制备方法及其用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3914416A (en) * | 1966-12-23 | 1975-10-21 | Exsymol Sa | Certain monomethyl trisilanol mannuronate complexes for treating cellulitis |
| US3914426A (en) * | 1972-11-10 | 1975-10-21 | Pfizer | Piperidinesulfonylurea derivatives for lowering blood sugar levels |
| US3887561A (en) * | 1972-11-10 | 1975-06-03 | Pfizer | Piperidinesulfonylurea derivatives |
| US3829434A (en) * | 1972-11-10 | 1974-08-13 | Pfizer | Piperidinesulfonylurea derivatives |
| US3987172A (en) * | 1974-04-26 | 1976-10-19 | Pfizer Inc. | Piperidinesulfonylurea derivatives |
| US3944524A (en) * | 1974-04-26 | 1976-03-16 | Pfizer Inc. | 4-Substituted-1-piperidinesulfonamides |
| US3936455A (en) * | 1975-01-31 | 1976-02-03 | Pfizer Inc. | Piperidinesulfonylurea derivatives |
| DE2948434A1 (de) * | 1979-12-01 | 1981-06-11 | Hoechst Ag, 6000 Frankfurt | 1-piperidinsulfonylharnstoffe und verfahren zu ihrer herstellung |
| DE4032766A1 (de) * | 1990-10-16 | 1992-04-30 | Basf Ag | Phenylpiperidinoylamine und diese enthaltende arzneimittel |
| US5574843A (en) | 1991-04-26 | 1996-11-12 | Escom Ag | Methods and apparatus providing for a presentation system for multimedia applications |
| DE59401361D1 (de) * | 1993-02-23 | 1997-02-06 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
| DE4341655A1 (de) * | 1993-12-07 | 1995-06-08 | Hoechst Ag | Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika |
| DE19503136A1 (de) * | 1995-02-01 | 1996-08-08 | Hoechst Ag | Substituierte Thiophenylsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19647000A1 (de) * | 1996-11-14 | 1998-05-20 | Hoechst Ag | 3-Amido-chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE19832009A1 (de) * | 1998-07-16 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate |
| TR200100692T2 (tr) * | 1998-09-10 | 2001-07-23 | Aventis Pharma Deutschland Gmbh | Otonom sinir sisteminin disfonksiyonlarının önlenmesinde Benzensulfonil (Tiyo) ürelerin kullanımı |
| US6414036B1 (en) * | 1999-09-01 | 2002-07-02 | Van Beek Global/Ninkov Llc | Composition for treatment of infections of humans and animals |
-
2004
- 2004-12-18 DE DE102004061017A patent/DE102004061017A1/de not_active Withdrawn
-
2005
- 2005-12-07 DK DK05811326T patent/DK1828131T3/da active
- 2005-12-07 AU AU2005315927A patent/AU2005315927B2/en not_active Ceased
- 2005-12-07 JP JP2007545899A patent/JP5231807B2/ja not_active Expired - Fee Related
- 2005-12-07 MX MX2007006679A patent/MX2007006679A/es active IP Right Grant
- 2005-12-07 BR BRPI0515770-6A patent/BRPI0515770A/pt not_active IP Right Cessation
- 2005-12-07 CN CN2005800431711A patent/CN101080388B/zh not_active Expired - Fee Related
- 2005-12-07 EP EP05811326A patent/EP1828131B1/en not_active Expired - Lifetime
- 2005-12-07 ES ES05811326T patent/ES2306252T3/es not_active Expired - Lifetime
- 2005-12-07 KR KR1020077013758A patent/KR101261251B1/ko not_active Expired - Fee Related
- 2005-12-07 PT PT05811326T patent/PT1828131E/pt unknown
- 2005-12-07 AT AT05811326T patent/ATE397588T1/de active
- 2005-12-07 DE DE602005007381T patent/DE602005007381D1/de not_active Expired - Lifetime
- 2005-12-07 WO PCT/EP2005/013087 patent/WO2006063722A1/en not_active Ceased
- 2005-12-07 CA CA2590405A patent/CA2590405C/en not_active Expired - Fee Related
-
2007
- 2007-06-10 IL IL183807A patent/IL183807A/en not_active IP Right Cessation
- 2007-06-12 US US11/761,565 patent/US8586612B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE397588T1 (de) | 2008-06-15 |
| BRPI0515770A (pt) | 2008-07-29 |
| CA2590405A1 (en) | 2006-06-22 |
| KR20070086366A (ko) | 2007-08-27 |
| JP5231807B2 (ja) | 2013-07-10 |
| EP1828131B1 (en) | 2008-06-04 |
| AU2005315927B2 (en) | 2012-02-09 |
| DE102004061017A1 (de) | 2006-06-22 |
| CN101080388B (zh) | 2010-12-22 |
| EP1828131A1 (en) | 2007-09-05 |
| HK1113353A1 (en) | 2008-10-03 |
| JP2008524132A (ja) | 2008-07-10 |
| US8586612B2 (en) | 2013-11-19 |
| IL183807A (en) | 2011-10-31 |
| ES2306252T3 (es) | 2008-11-01 |
| KR101261251B1 (ko) | 2013-05-07 |
| AU2005315927A1 (en) | 2006-06-22 |
| IL183807A0 (en) | 2007-09-20 |
| PT1828131E (pt) | 2008-07-24 |
| US20080033016A1 (en) | 2008-02-07 |
| CN101080388A (zh) | 2007-11-28 |
| WO2006063722A1 (en) | 2006-06-22 |
| MX2007006679A (es) | 2007-08-14 |
| CA2590405C (en) | 2013-03-12 |
| DE602005007381D1 (de) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072784L (no) | Pyridenkarboksamidderivater for anvendelse som anticancer midler | |
| MXPA06011194A (es) | Tiadiazolidinonas como inhibidores de gsk-3. | |
| NO20071776L (no) | Kinoksaliner som B RAF inhibitorer. | |
| NO20073719L (no) | Kjemiske forbindelser | |
| NO20082709L (no) | Kjemiske forbindelser | |
| NO20051165L (no) | Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet | |
| ATE290525T1 (de) | Acylaminoalkyl-substituierte benzolsulfonamidderivate | |
| TNSN04237A1 (en) | N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris | |
| WO2005080345A3 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| NO20082690L (no) | Kjemiske forbindelser | |
| DE60006936D1 (de) | Substituierte 4-amino-2-aryltetrahydrochinazoline, deren herstellung, deren verwendung und diese enthaltende pharmazeutische zusammenstellungen | |
| MY139310A (en) | Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as. medicament or diagnostic aid, and medicament comprising them | |
| MX2009012644A (es) | Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden. | |
| MXPA05011267A (es) | Derivados de la triaza-y tetraaza-antracenodiona, su preparacion y su uso como productos farmaceuticos. | |
| DK1828131T3 (da) | Piperidinsulfonylurinstoffer og -thiourinstoffer, deres fremstilling, deres anvendelse og farmaceutiske sammensætninger indeholdende samme | |
| CA2337397A1 (en) | 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same | |
| NO330964B1 (no) | Kolkisosidanaloger | |
| YU81701A (sh) | Cinamoilaminoalkil-supstituisani derivati benzensulfonamida | |
| NO20073710L (no) | Kjemiske forbindelser | |
| NO20053825L (no) | Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer. | |
| NO20062635L (no) | Pentafluorsulfanyl-benzoylguanidiner, produksjonsmetode, deres anvendelse som medikamenter eller diagnostiserende midler og medikamenter inneholdende disse | |
| ATE410414T1 (de) | Heteroarylacryloylaminoalkyl-substituierte benzolsulfonamidderivate, deren herstellung, deren verwendung und pharmazeutische zusammensetzungen, die diese verbindungen enthalten | |
| WO2002083641A3 (en) | Amino-aza-cyclohexanes for the treatment of malaria | |
| CA2310055A1 (en) | New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them | |
| WO2005007104A3 (en) | Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease |